Balyasny Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,860
Closed -$240K 2100
2024
Q3
$240K Sell
5,860
-5,413
-48% -$221K ﹤0.01% 1753
2024
Q2
$434K Sell
11,273
-361,849
-97% -$13.9M ﹤0.01% 1504
2024
Q1
$16M Buy
373,122
+327,097
+711% +$14M 0.03% 547
2023
Q4
$1.71M Sell
46,025
-1,065,879
-96% -$39.5M ﹤0.01% 1070
2023
Q3
$40.3M Buy
+1,111,904
New +$40.3M 0.08% 265
2023
Q1
Sell
-2,064,244
Closed -$72.5M 2377
2022
Q4
$72.5M Buy
2,064,244
+1,288,198
+166% +$45.3M 0.2% 99
2022
Q3
$22.8M Buy
776,046
+489,102
+170% +$14.4M 0.07% 324
2022
Q2
$15.6M Sell
286,944
-617,344
-68% -$33.6M 0.05% 411
2022
Q1
$49.2M Buy
904,288
+684,554
+312% +$37.3M 0.16% 114
2021
Q4
$12.1M Sell
219,734
-189,430
-46% -$10.4M 0.04% 488
2021
Q3
$19.5M Buy
+409,164
New +$19.5M 0.08% 311
2021
Q2
Hold
0
1825
2021
Q1
Hold
0
1697
2020
Q2
Sell
-87,428
Closed -$4.14M 1105
2020
Q1
$4.14M Buy
+87,428
New +$4.14M 0.05% 393
2018
Q2
Hold
0
1707
2018
Q1
Sell
-626,873
Closed -$27.8M 1845
2017
Q4
$27.8M Buy
626,873
+452,423
+259% +$20.1M 0.09% 284
2017
Q3
$8.85M Buy
+174,450
New +$8.85M 0.03% 456
2017
Q2
Sell
-224,775
Closed -$11.8M 1341
2017
Q1
$11.8M Buy
224,775
+201,815
+879% +$10.6M 0.06% 380
2016
Q4
$1.11M Sell
22,960
-70,489
-75% -$3.39M 0.01% 806
2016
Q3
$5.04M Sell
93,449
-573,691
-86% -$30.9M 0.03% 493
2016
Q2
$36.1M Buy
667,140
+412,296
+162% +$22.3M 0.23% 101
2016
Q1
$12.9M Buy
+254,844
New +$12.9M 0.08% 271
2015
Q4
Sell
-107,615
Closed -$5.17M 1166
2015
Q3
$5.17M Buy
107,615
+99,638
+1,249% +$4.79M 0.04% 433
2015
Q2
$415K Buy
+7,977
New +$415K ﹤0.01% 659
2014
Q4
Sell
-512,097
Closed -$29.4M 521
2014
Q3
$29.4M Buy
+512,097
New +$29.4M 0.23% 80
2014
Q2
Sell
-55,270
Closed -$3.69M 485
2014
Q1
$3.69M Buy
+55,270
New +$3.69M 0.04% 316
2013
Q3
Sell
-150,326
Closed -$9.39M 470
2013
Q2
$9.39M Buy
+150,326
New +$9.39M 0.16% 123